Qiang Li

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

Yuankai Shi, Li Zhang, Xiaoqing Liu et al. · The Lancet Oncology · 2013 · 420 citations

Double-blind Phase 3, Medicine, Metronomic Therapy +9

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

Baohui Han, Kai Li, Yizhuo Zhao et al. · British Journal of Cancer · 2018 · 260 citations · Full text

Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma

Jianmin Liu, Wei Ni, Qiao Zuo et al. · New England Journal of Medicine · 2024 · 147 citations

Risk factors for carbapenem-resistant<i>Klebsiella pneumoniae</i>infection/colonization and predictors of mortality: a retrospective study

Yang Jiao, Yanghua Qin, Jiajun Liu et al. · Pathogens and Global Health · 2015 · 102 citations · Full text

Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis

Yong Gao, Zhiliang Jia, Xiangyu Kong et al. · Cancer Research · 2011 · 95 citations · Full text